Mutations in a 69-bp region of the rpoB gene associated with rifampin resistance (Rif r ) in 100 isolates (82 Rif r ) from three states of Brazil were studied. Twenty-one different kinds of mutations were identified in the Rif r isolates, and six new alleles are described.
Sequencing of rpoB.
To detect the mutations associated with Rif r , a 157-bp region of the rpoB gene was sequenced. A loopful of bacteria was suspended in 500 l of TE (10 mM Tris, 1 mM EDTA, pH 8), and the DNA was extracted using cetyltrimethyl ammonium bromide as described previously (17) . Purified M. tuberculosis DNA from the clinical isolates and reference strain H 37 RV was used to produce a 157-bp fragment of the rpoB gene, from nucleotide 1846 to 2002 (GenBank accession no. U12205) by using the primers TR9 (5Ј-TC GCCGCGATCAAGGAGT) and TR8 (5Ј-TGCACGTCGCG GACCTCCA) by the protocol described by Telenti et al. (15) . The unincorporated nucleotides and primers were separated from the amplified DNA using MicroSpin columns (Pharmacia Biotech). Manual sequencing was carried out with the Thermo Sequenase Radiolabeled Terminator Cycle Sequencing kit (Amersham) according to the manufacturer's instructions and using the primers described above. For each sample the sequence was examined twice in one direction, using as a template the products of two independent amplification reactions. The isolates that showed new mutations were sequenced again using the BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems) on an ABI Prism 310 genetic analyzer (Perkin-Elmer).
Mutations in the rpoB gene of Rif r M. tuberculosis isolates from RS. In this group, DNA sequence analysis of 38 resistant isolates revealed 9 different kinds of missense mutations within a 157-bp region of the rpoB gene. All isolates had a single-point mutation, and the highest frequency of mutation was observed in the codon Ser-531 (55%). Point mutations in codons 526 (29%), 516 (8%), 511 (3%), and 522 (3%) were also observed ( Sixteen isolates presented one point mutation in codons 531 (52%), 516 (8%), and 513 (4%), while one isolate (4%) had a 4-codon deletion (515 to 518) and another isolate contained a point mutation in one codon (513) and a 3-codon deletion (514 to 516). Four Rif r isolates (16%) of M. tuberculosis contained point mutations in two separate codons, resulting in two amino acid substitutions for each isolate (513 and 514; 511 and 515; 531 and 526; and 511 and 516). One isolate had point mutations in three separate codons (524, 525, and 526) and a onecodon deletion (527) ( Table 2) . One M. tuberculosis Rif r isolate contained no mutations within the 157-bp region of the rpoB gene. Four new alleles were identified in this group, all involving changes in two or more codons. Isolate RJ37 showed changes in codons 514 and 531. In isolate RJ48, the codons 524, 525, and 526 changed, together with a deletion of codon 527. Isolate RJ49 showed a deletion of codons 514 to 516 associated with a change in codon 513, and isolate RJ55 showed a deletion of four codons (515 to 518).
General analysis. Twenty-one different types of mutations were identified in 82 Rif r M. tuberculosis clinical isolates, and six new alleles were identified ( Table 2 ). Most of them were single-nucleotide mutations (81%) involving seven codons. Eleven isolates (13%) exhibited more complex mutations. No silent substitutions were observed in the rpoB gene region examined for any of the M. tuberculosis isolates analyzed in this study. The codons most frequently affected by point mutations were 531, 526, and 516, with frequencies of 54%, 21%, and 7%, respectively. Although codon 526 was the second most affected, in Rif r isolates from RJ no mutation restricted to this codon was observed. No mutations were revealed in the rpoB segment sequenced from 18 Rif s isolates. Three Rif r isolates (4%) contained no mutations in this sequenced region, although these isolates were resistant to rifampin as determined by the proportional method.
The presence of mutations in a restricted region of the rpoB gene has been found in more than 96% of M. tuberculosis strains with various levels of rifampin resistance (4, 6, 10, 15, 18) . While more than 20 distinct missense mutations within the 69-bp hypervariable region of rpoB accounting for rifampin resistance in M. tuberculosis have been reported (9) , two of these mutations (Ser 531 3Leu and His 526 3Tyr) account for Ն65% (61% in our study) of rifampin resistance (6, 15, 16) . These substitutions were considered important to the acquisition of rifampin resistance, and it is clear that these two amino acids are critical sites for this characteristic.
In our study, we observed that 82% of the M. tuberculosis isolates with the Rif r phenotype contained missense mutations which led to amino acid substitutions at the Ser 531 (54%), His 526 (21%), and Asp 516 (7%) residues. Similar mutations and frequencies of codon substitution in Rif r M. tuberculosis have been reported previously (6, 7, 13, 14, 15 In general, isolates from RS and SP showed some similarity in the mutation frequencies. Samples from RJ showed a wider range of the mutations described above. Some of the mutations observed in RJ isolates were not found in other isolates analyzed in this work and in isolates from other published studies. , SP17, SP18, SP24, SP26, SP27, SP28, RJ30, RJ32, RJ38, RS02, RS34, RS40, RS6562, RS6580, RS6756,  RS6965, RS7084, RS7205, RS7242, RS7365, RS7484, RS7506, RS7543, RS8029, SP08, RJ41, RJ48, RS6573 ............................................................................................................................................................(R) RIF, INH, SM, PZA  RJ44, RS7681 ..................................................................................................................................................................................(R) RIF, INH, SM, EMB  SP13, RJ54, RS7704 .......................................................................................................................................................................(R) RIF, INH, PZA, ETH  RS7253, RS7256, RS7454 ..............................................................................................................................................................(R) RIF, INH, EMB, ETH  RJ49..................................................................................................................................................................................................(R) RIF, INH, SM, PZA, ETH  RS07 ............................................................................................................................................................................................ RJ46, RJ47, RJ55...............................................................................................................................(R Further studies must be done to find an explanation for such differences. Sequence analysis identified no mutation in three of the isolates tested, although these isolates were resistant to rifampin. Similar observations have been reported by others (6, 7, 15) and suggest that mutations located outside the region of analysis can result in rifampin resistance. Another possibility is that in these resistant strains, changes have occurred in genes whose products participate in antibiotic permeation or metabolism (6) . No silent mutations were observed in the sequenced regions of rifampin-susceptible or -resistant M. tuberculosis isolates in this analysis.
No association was found between particular mutations in the rpoB gene and drug susceptibility patterns of MDR-TB isolates, supporting the view that the mutations leading to rifampin resistance are independent events unrelated to these mutations affecting the development of resistance to the others antibiotics tested (18) .
In this study, we identified mutations in rifampin-resistant M. tuberculosis strains from Brazil that were commonly found in strains from other parts of the world. We found six new alleles, four of them in isolates from Rio de Janeiro.
Nucleotide sequence accession numbers. The new alleles found in this study have been deposited in GenBank under accession no. AF143771, AF146567, AF147030, AF147031, AF147033, and AF147034. 
